Get the latest news, inspiring stories, upcoming events, and valuable support services delivered straight to your inbox.
ALL NEWS
Filter by type
NICE does not recommend NHS use of efgartigimod for treating generalised myasthenia gravis
January 24, 2025
New drug for Duchenne muscular dystrophy to be made available in Scotland
January 13, 2025
Muscle Groups dates announced
January 8, 2025
Duchenne muscular dystrophy treatment givinostat conditionally approved in the UK
December 20, 2024
Disappointing results from phase 2 clinical trial for Duchenne muscular dystrophy
December 19, 2024
Phase 2 clinical trial, CANYON, shows potential at reducing muscle damage in Becker muscular dystrophy
December 18, 2024
NICE recommends new drug for Duchenne muscular dystrophy to be made available in England
December 10, 2024
One month in: insights from our CEO, Andy Fletcher
December 6, 2024
Award win at Charity Comms Inspiring Communicator Awards
December 4, 2024
Dare to Defy: Oscar and Seb’s journey in accessible sport
December 2, 2024
People living with neuromuscular conditions discuss ‘The Remarkable Life of Gaming’ at Netflix event
November 22, 2024
The global search for new treatments: highlights from the Annual Congress of the World Muscle Society
November 22, 2024